Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019

SELL
$6.44 - $14.29 $14.8 Million - $32.9 Million
-2,302,363 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$11.87 - $14.84 $752,831 - $941,197
63,423 Added 2.83%
2,302,363 $32.6 Million
Q4 2018

Feb 11, 2019

SELL
$13.09 - $21.49 $3.69 Million - $6.06 Million
-282,124 Reduced 11.19%
2,238,940 $30.3 Million
Q3 2018

Oct 30, 2018

SELL
$16.4 - $24.27 $1.02 Million - $1.51 Million
-62,098 Reduced 2.4%
2,521,064 $55.9 Million
Q2 2018

Aug 02, 2018

BUY
$13.95 - $20.2 $36 Million - $52.2 Million
2,583,162 New
2,583,162 $42.4 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.25B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.